New pharmaceutical base to be built in WND

Signing ceremony between Jemincare Group and Wuxi National Hi-tech District is held on Sept 10. [Photo/wxrb.com]

The Jiangxi-based pharmaceutical company Jemincare Group signed an agreement Sept 10 to build a new production base in Wuxi National Hi-tech District (WND).

With investment exceeding 1.6 billion yuan ($234.5 million), the production base will work on the research and development (R&D) and production of a specific neutralizing antibody innovative drug and a macromolecular biological drug.

It is the third time that Jemincare Group has invested in WND, aiming to expand its business in the macromolecular biopharmaceutical field. The Wuxi base is expected to promote cooperation with Jemincare's Zhangjiang Institute and Wuxi Shanhe Group.

"WND has a good investment and industrial environment and professional investment promotion services," said Li Yihai, chairman of Jemincare Group, adding that he was bullish about the development of the new project.

Officials from WND said they will give full support to carry out win-win cooperation with Jemincare Group.

In recent years, WND has developed a biomedical industry cluster mainly focused on innovative drugs and preparations, medical devices and diagnostic reagents, smart medical treatment and health services.